ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,482.87
0.09%
US Tech 100
19,349.00
0.44%
Dow Jones
39,164.06
0.00%
Brent Oil
85.535
0.14%
Bitcoin
61,670.72
0.10%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Valneva Se (0OB3) Quote

Valneva Se

Valneva Se (0OB3)

LSE
3.455
0.00
( 0.00% )
Updated: 20:00:00
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.455
Bid
3.37
Ask
3.54
Volume
15,406
0.00 Day's Range 0.00
3.455 52 Week Range 3.455
Market Cap
436.184M
Previous Close
3.455
Open
-
Last Trade
1000
@
3.15
(O)
Last Trade Time
07:47:56
Financial Volume
-
VWAP
-
Average Volume (3m)
30,719
Shares Outstanding
138,912,000
Dividend Yield
-
PE Ratio
-4.30
Earnings Per Share (EPS)
-0.73
Revenue
175.73M
Net Profit
-101.43M

About Valneva Se

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.valneva.com
Headquarters
Saint-herblain, Loire-atlantique, Fra
Founded
1970
Valneva Se is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0OB3. The last closing price for Valneva was 3.46 €. Over the last year, Valneva shares have traded in a share price range of 3.455 € to 3.455 €.

Valneva currently has 138,912,000 shares outstanding. The market capitalization of Valneva is 436.18 € million. Valneva has a price to earnings ratio (PE ratio) of -4.30.

0OB3 Latest News

More News

Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board

Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board Saint-Herblain (France), June 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext...

June 26 2024
GlobeNewswire Inc.

Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®

Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ® Saint-Herblain (France), June 24, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty...

June 24 2024
GlobeNewswire Inc.

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update Saint-Herblain (France), June 5, 2024 – Valneva SE (Nasdaq: VALN; Euronext...

June 05 2024
GlobeNewswire Inc.

VALNEVA - Déclaration d’actions et de droits de vote : 31 mai 2024

VALNEVA - Déclaration d’actions et de droits de vote : 31 mai 2024 VALNEVA Déclaration d’actions et de droits de vote 31 mai 2024______________________________________________________________...

June 04 2024
GlobeNewswire Inc.

Valneva annonce sa participation à différentes conférences investisseurs du mois de juin

Valneva annonce sa participation à différentes conférences investisseurs du mois de juin Saint-Herblain (France), le 4 juin 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société...

June 04 2024
GlobeNewswire Inc.

Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases

Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases Saint-Herblain (France), June 3, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a...

June 03 2024
GlobeNewswire Inc.

Valneva reçoit un avis positif du CHMP pour une autorisation de mise sur le marché en Europe de son vaccin contre le chikungunya

Valneva reçoit un avis positif du CHMP pour une autorisation de mise sur le marché en Europe de son vaccin contre le chikungunya    En cas d’approbation, IXCHIQ® deviendra le premier vaccin...

May 31 2024
GlobeNewswire Inc.

Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook

Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook  Total revenues of €153.7 million, including product sales of €144.6 million Product sales surpassed pre-pandemic...

March 20 2024
UK Regulatory

Valneva publie ses résultats financiers 2023 et fait un point sur son activité et ses perspectives financières

Valneva publie ses résultats financiers 2023 et fait un point sur son activité et ses perspectives financières  Chiffre d’affaires total de 153,7 millions d’euros dont 144,6 millions d’euros de...

March 20 2024
UK Regulatory

Valneva annonce un report de la date de début de remboursement du prêt contracté avec les sociétés Deerfield et OrbiMed

Valneva annonce un report de la date de début de remboursement du prêt contracté avec les sociétés Deerfield et OrbiMed Les remboursements sont différés de 18 mois et débuteront en janvier 2026 au...

March 18 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1003.4553.4553.455260853.455DE
4003.4553.4553.455335503.455DE
12003.4553.4553.455307193.455DE
26003.4553.4553.455341813.455DE
52003.4553.4553.455353173.455DE
156003.4553.4553.455409273.455DE
260003.4553.4553.455381903.455DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
COSMCosmos Health Inc
$ 1.12
(64.95%)
10.22M
AAGRAfrican Agriculture Holdings Inc
$ 0.3651
(51.12%)
29.51M
CARMCarisma Therapeutics Inc
$ 1.71
(33.59%)
3.64M
SGMOSangamo Therapeutics Inc
$ 0.51
(27.95%)
23
ESPREsperion Therapeutics Inc
$ 2.86
(23.81%)
1.66M
NXLNexalin Technologies Inc
$ 1.86
(-37.16%)
652.76k
ACCDAccolade Inc
$ 4.48
(-29.89%)
163.3k
ELTXElicio Therapeutics Inc
$ 5.04
(-26.85%)
4.03k
MEDSTRxADE HEALTH Inc
$ 9.84
(-25.23%)
3.64k
PRPOPrecipio Inc
$ 4.00
(-19.52%)
2
AAGRAfrican Agriculture Holdings Inc
$ 0.3636
(50.50%)
29.53M
LUCYInnovative Eyewear Inc
$ 0.4062
(23.09%)
11.07M
COSMCosmos Health Inc
$ 1.12
(64.95%)
10.22M
HUGEFSD Pharma Inc
$ 0.1821
(7.12%)
6.68M
FFIEFaraday Future Intelligent Electric Inc
$ 0.5674
(-5.43%)
4.89M

Discussion

View Full Feed
WinstonCup WinstonCup 5 minutes ago
They were both terrible!
imi
WDLF
LetGoodTimesRoll LetGoodTimesRoll 5 minutes ago
$RNVA =====>KAPOW POW KABOOM $$$$$$
RNVA
Solarman Solarman 5 minutes ago
$MMMW prepares for a marketable stationary solar device to lower electric prices.
MMMW
conix conix 5 minutes ago
Agree with David Axelrod with his question to Republicans--what are they going to do if the Dems replace Biden with a moderate Democrat?

nypost.com/wp-content/uploads/sites/2/2024/06/joe-biden-donald-trump-cnn-84588021_24d338.jpg?quality=75&strip=all
KeepItRealistic KeepItRealistic 5 minutes ago
$BURU limited deep discount shares

https://x.com/keeprealistic/status/1806659955920904661?s=46&t=IJ2EAuutIm5R5c1kklP3-w

BURU
scortech scortech 6 minutes ago
Looks like liberal media setup Joe to try to make him bow out
CGAC
MetaMonster MetaMonster 6 minutes ago
https://sifted.eu/articles/ai-startups-clinical-trials-cancer-big-pharma-brnd
RNAZ
Spuds McKenz66 Spuds McKenz66 6 minutes ago
mm's want this way higher , start buying FFIE
FFIE
zab zab 6 minutes ago
Trumps love of Putin and Russia never fades.
DJT
Solarman Solarman 7 minutes ago
$MMMW news today is good.
MMMW
Investor2014 Investor2014 7 minutes ago
A well written and correct analysis of OLE studies.I know our WGT lot will incorrectly take issue with this from a standpoint of bias and blissful ignorance.
AVXL
louieforpar louieforpar 7 minutes ago
For the record……..

I have never posted or been a follower of polls whether it be from Presidential or debates. Also,I have never claimed Biden to be the next President.
My posts for the most part have been link fueled supported by the facts as reported.

It’s cl
DJT
scortech scortech 7 minutes ago
Absolutely right, put him in survival mode
CGAC
Nemesis18 Nemesis18 7 minutes ago
Adjuvant treatment costs the NHS about $1200 per patient, with 95% of that outlay Radiotherapy.

Whole Temozolomide is negligible in comparison
NWBO
KeepItRealistic KeepItRealistic 8 minutes ago
$BURU opportunity

https://x.com/keeprealistic/status/1806659955920904661?s=46&t=IJ2EAuutIm5R5c1kklP3-w

BURU
KeepItRealistic KeepItRealistic 8 minutes ago
$BURU opportunity

https://x.com/keeprealistic/status/1806659955920904661?s=46&t=IJ2EAuutIm5R5c1kklP3-w

BURU
B_B! B_B! 8 minutes ago
Another strange “Press Release”, it’s misleading, I think.
PLUG
Solarman Solarman 8 minutes ago
$MMMW announces debt elimination to prepare for a new marketable product.
MMMW
TheFinalCD TheFinalCD 8 minutes ago
AAGR 29'S who caught that dip

https://x.com/READY_2_PROFIT/status/1806659698059321619
AAGR
toncatmad toncatmad 8 minutes ago
Magoo you’ve done it again!!

Majority Holding Worthless Shares Strong!!

Only a rookie bag holder would think that is a good thing
surfkast surfkast 8 minutes ago
Application to European Medicines Agency

Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
June 28 2024 - 7:00AM

Alert
Print
Share On Facebook

Iovance
IOVA
threebabiesbusy threebabiesbusy 9 minutes ago
Good morning. TGIF!!
FSRNQ
tulla236a tulla236a 9 minutes ago
end of qtr, end of first month of cat. let’s see what the cat system wil reveal. will our government react to it or continue to turn a blind eye? big time focus will be on banks the coming months. derivatives and commercial loan defaults will continue to get worse. loss reserve will kill their
AMC
Louied91 Louied91 10 minutes ago
$MMMW Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11

https://www.newsfilecorp.com/release/214776

Worcester, Massachusetts--(Newsfile Corp. - June 28, 2024) - Mass Megawatts (OTC Pi
MMMW

Your Recent History

LSE
0OB3
Valneva
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved